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Background: Autism spectrum disorder is a severe early onset neurodevelopmental disorder with high heritability
but significant heterogeneity. Traditional genome-wide approaches to test for an association of common variants
with autism susceptibility risk have met with limited success. However, novel methods to identify moderate risk
alleles in attainable sample sizes are now gaining momentum.
Methods: In this study, we utilized publically available genome-wide association study data from the Autism
Genome Project and annotated the results (P <0.001) for expression quantitative trait loci present in the parietal
lobe (GSE35977), cerebellum (GSE35974) and lymphoblastoid cell lines (GSE7761). We then performed a test of
enrichment by comparing these results to simulated data conditioned on minor allele frequency to generate an
empirical P-value indicating statistically significant enrichment of expression quantitative trait loci in top results from
the autism genome-wide association study.
Results: Our findings show a global enrichment of brain expression quantitative trait loci, but not lymphoblastoid cell
line expression quantitative trait loci, among top single nucleotide polymorphisms from an autism genome-wide
association study. Additionally, the data implicates individual genes SLC25A12, PANX1 and PANX2 as well as pathways
previously implicated in autism.
Conclusions: These findings provide supportive rationale for the use of annotation-based approaches to genome-wide
association studies.
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Autism spectrum disorder (ASD) is characterized by
impairments in three core domains: development of so-
cial interaction; language and communication develop-
ment; and restricted or circumscribed interests and
repetitive behaviors [1]. By definition, children with aut-
ism show impairments in all three areas, though the de-
gree to which each is affected varies. The study of
autism genetics began with twin studies conducted as
early as the 1970s [2], indicating a strong heritable com-
ponent. Since then, the autism genetics field has pro-
gressed to include linkage, association, copy number
variation and candidate gene studies targeting the broad
autism diagnosis as well as specific endophenotypes of
autism. The discovery of genetic variants involved in
autism has been confounded by phenotypic, genetic and
allelic heterogeneity, multiple modes of transmission, in-
consistent application of diagnostic criteria and un-
known environmental risks. Progress has been made in
our understanding of the genetic architecture of autism
despite these complexities. However, few genes harbor-
ing common risk factors have been convincingly impli-
cated in the etiology of autism.
Multiple traditional genome-wide association studies
(GWAS) of ASD have been published with limited
power to detect common variants contributing to risk.
Genome-wide significantly associated risk alleles have
been identified on chromosome 5p14 [3,4], 5p15 [5] and
20p12.1 [6]. The latter study was the largest to date and
included over 1,500 parent–child-trio families in the
analysis. The single genome-wide significant result found
on chromosome 20p12.1 fell within the MACRO domain
containing protein 2 gene. However, at least one subse-
quent study has failed to replicate this association [7].
Recent studies have shown that novel analytic approaches
using GWAS data can increase the power to identify statis-
tically significant relationships. For example, Lu and Cantor
describe a method that allows for sex-specific associations,
resulting in highly significant findings at the ryanodine re-
ceptor 2 locus (P <3.9× 10-11) in a multiplex autism dataset
[8]. Additionally, several pathway-based analyses of autism
GWAS have recently been published, showing enrichment
of sub-genome-wide significant associations with pathways
of prior interest in autism. For example, Yaspan and
colleagues applied their method (pathway analysis by
randomization incorporating structure) to the available
Autism Genetic Resource Exchange GWAS dataset, sub-
sequently identifying over-representation of pathways
involved in ubiquitination (supporting a pathway analysis
in Glessner et al. [9]) as well as synthesis and degradation
of ketone bodies [10]. Anney and colleagues also pub-
lished a pathway-based analysis, which successfully ap-
plied the SNP ratio test methodology to genome-widedata from Autism Genome Project (AGP) families, result-
ing in a number of convincingly implicated pathways [6].
Mining of existing autism GWAS data is proving to be a
valuable undertaking with the potential to provide signifi-
cant insight into the biology and common risk assessment
of ASD.
Recent studies providing thorough investigation of top
signals from GWAS of a number of complex disorders
have shown enrichment for expression quantitative trait
loci (eQTL) in relevant tissues [11-13]. These findings
suggest that SNPs with significant functional impact on
the expression of genes are more likely to be associated
with disease phenotypes [11]. Based on this finding, our
group sought to determine if brain-specific eQTL were
over-represented in the most significant association from
a recently published autism GWAS and whether the spe-
cific genes implicated as enriched might highlight new,
or help cement existing, candidate genes and pathways.
We used publically available data from the AGP GWAS
[6], the SNP and CNV Annotation Database [14] and
genome-wide expression datasets in brain [13] to test for
enrichment of eQTL (those previously identified in
transformed lymphocytes and two regions of the brain,
parietal lobe and cerebellum), among top nominally
associated SNPs from reported autism GWAS.
Methods
Study design
This study was designed to detect enrichment of brain
eQTL amongst top signals from the recent AGP GWAS
by Anney et al. [6]. All human subjects research in the
study by Anney et al. was conducted in accordance with
the Helsinki Declaration and with oversight by the ap-
propriate site-specific Internal Review Board [6]. A sche-
matic of the method utilized in this study is presented in
Figure 1. Briefly, four total lists of SNPs were collected
from the additional files of the paper by Anney et al.
These include one SNP list from each primary analysis
(Spectrum diagnosis [Spec]|All Ancestry [All]; Strict
diagnosis [Strict]|All; Spec|Western European Ancestry
[WestEur]; Strict|WestEur) meeting a GWAS P-value
threshold of 10-3. Three of these analyses reflect strata
of the broadest diagnostic (spectrum) and ancestry (all)
categories and therefore these analyses are overlapping
and non-independent. The top SNPs from each of these
GWAS were analyzed for eQTL enrichment in two differ-
ent brain tissues (parietal and cerebellum) as well as trans-
formed lymphoblastoid cell lines (LCLs), as described
below. Comparison of each SNP list to a randomized null
distribution of SNPs (described below) within each eQTL
database yielded an empirically determined enrichment
P-value. Furthermore, the targets for those eQTL present
within the four AGP GWAS lists and showing enrichment
Figure 1 A flowchart showing the study design. One SNP list from each of the four primary analyses in the publication from Anney et al. [6]
(totaling four lists of SNPs) was annotated for eQTL information against an LCL eQTL dataset (http://www.SCANdb.org [14]), parietal tissue and
cerebellar tissue. No enrichment was found in any of the LCL annotated datasets, enrichment was found in the parietal lobe for all four analyses
and in cerebellar tissue for two of the datasets. The eQTL found in each of the six analyses were combined in order to identify unique eQTL
signals that appeared in one or more tissues and in one or more primary analyses. This complete list of unique eQTL signals was then
investigated for genes and pathways of interest in autism. eQTL: expression quantitative trait loci; LCL: lymphoblastoid cell line.
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conducted on these eQTL targets to determine if particular
genes, gene families or pathways were strongly implicated
by eQTL present in any of the primary AGP GWAS
analyses.Autism genome project genome-wide association study
data collection
The methods and samples used for the AGP GWAS are
described in depth in the publication by Anney et al. [6].
Additional files published with that analysis contained
all SNPs significant at P <0.001 under an additive model
from which the primary analyses were extracted. The
lists of significant SNPs came from family-based primary
analyses including those stratified by diagnosis subtype
and population. In total, four lists of SNPs, significant atTable 1 Enrichment results for primary analyses
Diagnosis Ancestry Parietal enrichment
Spectrum All P= 0.004
Nsnps = 1262
Nsubs = 1385
Strict All P <0.001
Nsnps = 991
Nsubs = 812
Spectrum Western European P= 0.005
Nsnps = 1209
Nsubs = 1230
Strict Western European P <0.001
Nsnps = 998
Nsubs = 720
Results for primary analyses are shown by diagnostic category and ancestry. The nu
number of SNPs (Nsnps) that were significant at a GWAS P <10
-3 and went into the
The empirically derived enrichment P-value for each diagnostic and ancestry catego
GWAS: genome-wide association study; SNP: single nucleotide polymorphism.a GWAS P <10-3 threshold, were taken from the publi-
cally available GWAS results published by Anney et al.
[6] (Table 1).Expression quantitative trait locus determination
eQTL data from LCLs were generated from 176 HapMap
European (CEU) and African (YRI) cell lines as described
previously (GSE7761) [15]. Cerebellar (GSE35974) and par-
ietal cortex (GSE35977) cis and trans eQTL were generated
from 153 individuals of European ancestry obtained from
the Stanley Medical Research Institute [13]. ComBat and
Surrogate Variable Analysis were used to adjust for batch
and both known and unknown covariate effects [16,17].
SNP genotyping was performed on the Affymetrix Gen-
ome-Wide Human SNP Array 5.0 (Affymetrix, Santa Clara,
CA, USA) and imputed, using MaCH to include allCerebellar enrichment Lymphoblastoid cell line
enrichment
P= 0.003 P= 0.502
P= 0.872 P= 0.110
P= 0.012 P= 0.503
P= 0.451 P= 0.496
mber of subjects (Nsubs) that went into the GWAS, and the subsequent
eQTL enrichment analysis is shown in each diagnostic and ancestry category.
ry in each tissue tested is also provided. eQTL: expression quantitative trait loci;
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ST Exon Array was used for gene expression profiling.
Imputed genotype dosage data were analyzed for associ-
ation with expression phenotypes using PLINK [20]. For
cis eQTL, defined as SNPs within 4 Mb of the probe site,
the corrected significance threshold for determining
eQTL status (eQTL P-value) was P <0.0001. For trans
eQTL, the eQTL P-value was corrected as 0.05/n, where
n = 25,834 probes for the expression data.Enrichment of top genome-wide association study signal
analysis
All ASD GWAS SNPs with a GWAS P ≤10-3 in the four
primary analyses were subsequently annotated with eQTL
information, including the strength of the evidence for the
impact of the polymorphism on expression. To test for en-
richment of eQTL among these top SNP associations,
1,000 randomized SNP sets were generated. Each of these
1,000 lists, comprising the simulated set of SNPs, included
the same number of SNPs as the original list of ASD
GWAS associations and contained only SNPs matching
the minor allele frequency distribution of the original list
of ASD GWAS SNPs. The random lists were sampled
without replacement from the set of typed SNPs on the
Illumina HumanHap610 array. Minor allele frequency
matching was conducted by classifying all Illumina
Hap610 platform SNPs into discrete minor allele fre-
quency bins at 5% intervals (0 to 5%, 5 to 10%, . . .,45 to
50%), followed by random selection of SNPs from the
same allele-frequency bins as those in the top signals. The
number of eQTL in each simulated set yields an empirical
distribution and an enrichment P-value, calculated as the
proportion of randomized sets in which the eQTL count
matches or exceeds the actual observed count in the list of
top SNP associations.Pathway analysis of significantly enriched brain
expression quantitative trait loci
The program PANTHER (http://www.pantherdb.org
[21]) was used to identify networks or gene families
represented by top autism GWAS eQTL. PANTHER’s
classification of genes and proteins provides functional-
ity to determine if gene annotations (that is, membership
in pathway or Gene Ontology) are over-represented in a
test gene list compared with expectation, given all genes
in the human genome. P-values generated by the pro-
gram are Bonferonni-corrected for the number of com-
parisons conducted. Of the 140 unique genes implicated
as eQTL targets from the four primary autism GWAS,
130 were mapped to identifiers in the PANTHER data-
base and analyzed for pathway, molecular function and
biological process terms that were over-represented
compared to expectation.Results
The focus of this study was to determine if enrichment
of brain eQTL (that is, SNPs that regulate brain
expressed genes) existed in the top signals from pub-
lished autism GWASs. To this end, we analyzed SNPs at
a GWAS P <10-3 for four primary analyses from the
published AGP GWAS [6].
Primary genome-wide association study enrichment
analyses
The primary GWAS enrichment analyses consist of two
stratifications including diagnosis and ancestry. We
observed significant enrichment of parietal (P=0.004) and
cerebellar (P <0.003) eQTL, but not LCL eQTL (P=0.502)
among the top signals from the most broadly inclusive
dataset of spectrum diagnosis including all ances-
tries (Figure 2). Similarly, enrichment of both parietal
(P=0.005) and cerebellar (P=0.012) eQTL persisted in the
spectrum diagnosis when limited to individuals of Western
European descent. Significant enrichment of parietal eQTL
(P <0.001), but not cerebellar (P=0.872) or LCL eQTL
(P=0.110) was identified in the Strict|All dataset (Figure 3).
We again observed significant enrichment of parietal
(P <0.001) eQTL but not cerebellar (P=0.45) or LCL
(P=0.49) eQTL in the Strict diagnosis when limited to
individuals of Western European descent. Results from all
analyses are summarized in Table 1.
Descriptive statistics from primary autism genome-wide
association study expression quantitative trait loci
enrichment analyses
SNPs from all four primary non-independent SNP lists
that were eQTL in either cerebellum or parietal tissues
contributed to a total number of 539 brain eQTL found
in the primary AGP GWAS top signals. In brief, of the
total 539 eQTL SNPs, 256 eQTL SNPs were uniquely
identified, meaning that the remaining 283 eQTL SNPs
were redundancies of the 256 unique eQTL SNPs. Of
the unique 256 eQTL SNPs, 214 (84%) were found to be
eQTL for only one gene. Forty-two (16%) eQTL SNPs
acted as eQTL for more than one gene. Of the 214 SNPs
that target only one gene, 124 (58%) act in cis and 88
(42%) act in trans. Of the 42 SNPs that target more than
one gene, 21 (50%) SNPs regulate all target genes in cis,
5 (12%) SNPs regulate all target genes in trans, and 16
(38%) SNPs are both trans and cis regulators of different
target genes. All eQTL from enrichment analysis are
provided in Additional file 1: Table S1.
From this total set of SNPs, 140 genes were uniquely
implicated as eQTL targets. Of these 140 genes, 62 (44%)
were cis implicated and 78 (56%) implicated in trans; the
proportion of cis implicated genes (in contrast to trans
implicated genes) is greater than expected in either cere-
bellum or parietal tissues based on the observed number
Figure 2 Histograms of expression quantitative trait loci enrichment analyses for Spect|All analyses. The gray histogram distributions
represent the null distribution created by 1,000 lists of randomly ascertained SNPs drawn from the 1 M array platform and conditioned on minor
allele frequency. The black dot represents the actual count of SNPs annotated as eQTL present in each tissue in the Spectrum|All Ancestry
analysis. We observed significant enrichment of parietal (P <0.004) and cerebellar (P <0.003) eQTL, but not LCL eQTL (P <0.502). eQTL: expression
quantitative trait loci; LCL: lymphoblastoid cell line; SNP: single nucleotide polymorphism.
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uniquely implicated genes, 71 (51%) genes were implicated
in only one analysis; 69 (49%) genes were detected in two
or more analyses; 20 (14%) genes were identified in three
or more analyses; and 14 (10%) genes were found in all
four analyses. There was relatively little overlap in the
eQTL target genes across tissues. In an analysis of theFigure 3 Histograms of expression quantitative trait loci enrichment
represent the null distribution created by 1,000 lists of randomly ascertaine
allele frequency. The black dot represents the actual count of SNPs annota
Significant enrichment of parietal eQTL (P <0.001), but not cerebellar (P <0
eQTL: expression quantitative trait loci; LCL: lymphoblastoid cell line; SNP: sbroadest diagnostic and ancestry category, only 18 (13%)
of the 140 brain-enriched genes were also targeted by
eQTL found in LCLs. Of these 18, only three (2%) were
identified in parietal, cerebellum and LCL tissues. Of the
140 brain-enriched genes, only 10 genes (7%) were found
in both cerebellum and parietal tissues. In all pairwise
comparisons of tissues, the overlap in the eQTL targetanalyses for Strict|All dataset. The gray histogram distributions
d SNPs drawn from the 1 M array platform and conditioned on minor
ted as eQTL present in each tissue in the Strict|All Ancestry analysis.
.872) or LCL (P <0.110) eQTL was identified in the Strict|All dataset.
ingle nucleotide polymorphism.
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exact test). All genes implicated in enrichment analyses
are given in Additional file 2: Table S2.
Gene and pathway level analysis from primary autism
genome-wide association study expression quantitative
trait loci enrichment analyses
We reviewed the function of those genes implicated in the
enrichment analysis to identify common pathways, gene
families or functions of said genes. The genes solute carrier
family 25 member 12 (SLC25A12), pannexin 1 (PANX1)
and pannexin 2 (PANX2) were strongly implicated in our
analyses. SLC25A12 was multiply-implicated by a unique
set of 31 SNPs, which was by far the largest number of
SNPs implicating a single transcript and was the only tran-
script implicated in such a way (Figure 4). These SNPs all
show a high degree of linkage disequilibrium and appear to
implicate an extended haplotype (Figure 5). Twenty-eight
of the 31 SNPs were found in more than one analysis and
two of those 28 SNPs were found in three analyses
(Figure 6). All SNPs implicating SLC25A12 were cis regula-
tors. All eQTL SNPs implicating SLC25A12, and additional
information such as SNPs in linkage disequilibrium
(r2> 0.8), are provided in Additional file 3: Table S3.The
genes PANX1 and PANX2 were also multiply-implicated.
PANX1 was identified as an eQTL target in all four of theFigure 4 Bar graph showing the number of expression quantitative t
the actual number of SNPs implicating each gene. The number of SNPs im
(r = 0.13). The blue line represents the number of analyses in which the gen
implicated is not significantly correlated with gene size (r = 0.09). A subsetprimary analyses. No genes were implicated by both cis and
trans eQTL; however, PANX1 was targeted by nine cis
eQTL and PANX2 was targeted by three trans eQTL.
Additionally, we sought to identify any overlap between
the eQTL implicated in this study and those recently pub-
lished by Voineagu and colleagues [22], who identified a
number of genes differentially expressed in autism and
matched control brains. We found that four of the 140
brain eQTL target genes from our list overlapped with the
1,153 differentially expressed genes identified by Voineagu
et al. [22]. These included SLC25A12, PANX2, calponin 3
acidic and cleavage and polyadenylation specificity factor
subunit 1.
Based on PANTHER analysis, we found modest evi-
dence of significant over-representation of 14 processes
and pathways of interest in autism, including structural
components of ribosomes (P <0.009), methyltransferase
activity (P< 0.05), the nicotinic acetylcholine receptor sig-
naling pathway (P< 0.02), sensory perception (P< 0.01),
and receptor activity (P< 0.05) among others (Table 2).
Discussion
This study sought to identify biologically meaningful
associations buried within top signals that did not meet
genome-wide significance thresholds from autism
GWAS results. Traditional GWAS in autism have beenrait loci signals across representative loci. The red line represents
plicating each gene is not significantly correlated with the gene size
e was implicated. The number of analyses in which the gene was
of genes is listed along the X-axis.
Figure 5 Linkage disequilibrium structure of SLC25A12 autism associated expression quantitative trait loci. Figure was generated using
Haploview and demonstrates the linkage disequilibrium structure of only those autism associated eQTL SNPs. Red shading is according to D’
values and r2 values are provided in the figure. Three haplotype blocks are identified, extending past the boundary of SLC25A12. SNPs in linkage
disequilibrium (European, Yorubin and Han Chinese + Japanese) with the SNPs shown here are provided in Additional file 3: Table S3. Four SNPs
provide 100% haplotype capture and are also provided in Additional file 3: Table S3. eQTL: expression quantitative trait loci; SNP: single
nucleotide polymorphism.
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sample sizes. To date, multiple traditional autism GWAS
have been published although it is important to note that
some of these studies use overlapping datasets [3-6]. We
believe that, while these studies might be underpowered
to identify signals that survive genome-wide correction,
their reported results do not reflect the full value of the
data.
There are excellent examples to date of such novel
methodologies providing additional insight into the role
of common genetic variants in complex human disor-
ders, including autism. Anney and colleagues in the
AGP also conducted a novel analysis of the present gen-
ome-wide data utilizing the SNP ratio test in an effort to
detect over-transmitted SNPs in predefined pathways of
interest, which subsequently identified multiple path-
ways and/or Gene Ontology terms enriched for asso-
ciated signals [23]. Interestingly, two of these pathways,ribosomal components and methyltransferase activity,
were also identified in the current study as pathways
regulated by eQTL-associated SNPs. Our study comple-
ments these pathway-based approaches and demon-
strates a method of utilizing expression based SNP
annotations to mine already existing analyses for disease
associations with functional variants in relevant tissues.
Our study identified significant enrichment of parietal
and cerebellum eQTL, but not LCL eQTL, among the
top SNP associations in all four of the primary AGP
GWAS identified by Anney et al. This pattern of results
showing significant enrichment in brain (the affected
and relevant tissue) and not in tissues peripheral to the
main pathology was also seen in a study of cis-regulatory
SNPs in bipolar disorder [13]. Similarly, Below et al. [12]
report enrichment of top signals from a type 2 diabetes
GWAS in tissues involved in pathogenesis (muscle and
adipose) but not LCLs. Additionally, we found no
Figure 6 Venn diagram of the single nucleotide polymorphisms
implicating SLC25A12. Thirty-one SNPs were identified in the Strict|
AllAncestry analysis as cis eQTL regulating SLC25A12 in parietal tissue.
Twenty-eight of those thirty-one SNPs were also identified as cis
eQTL for SLC25A12 in parietal tissue in the Strict|WestEur analysis.
Finally, two of those twenty-eight SNPs were also identified as cis
eQTL in parietal tissue in the Spect|WestEur analysis. eQTL:
expression quantitative trait loci; SNP: single nucleotide
polymorphism.
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GWAS implicated SNPs and the SNPs forming the null
distribution. Taken together, the minor allele matching,
the lack of a significant difference in distance to nearest
gene, and the fact that enrichment is found in some tis-
sues and not in others provide strong evidence against
possible sources of systematic bias.
There was very little overlap in the eQTL targets found
in parietal, cerebellum and LCLs. Only three target genes,
protein NIP-SNAP homologue 3A (NIPSNAP3A), TM2
domain containing protein 2 (TM2D2) and copine 1
(CPNE1), were present in all three tissues in the analysis
of the broadest diagnostic and ancestry categories. These
findings also strongly suggest that the most appropriate
tissue for further functional work is the tissue of path-
ology. This poses clear challenges for difficult to access
tissues, such as neurons. However, there is significant evi-
dence that human induced pluripotent stem cells, once
transformed into neurons, provide an invaluable source of
neuronal tissue from live patients in which to study cellu-
lar phenotypes [24-26]. Our study highlights the import-
ance of furthering the development of methods that allow
access to tissues involved in pathology.
While we expected, and observed, overlap in top sig-
nals between each primary GWAS, our findings showedan abundance of unique eQTL and implicated a total of
140 target genes. Additionally, three genes, SLC25A12,
PANX1 and PANX2, were strongly implicated by our
results. Two of these genes, SLC25A12 and PANX2, were
also identified in a recent study of genes differentially
expressed in the brains of individuals with autism com-
pared to control brains [22]. PANX2 is a protein impli-
cated by trans eQTL that modulates the timing of
neuroprogenitor commitment to a neuronal lineage in the
hippocampus [27]. It is located 500 kb proximal to SH3
and multiple ankyrin repeat domains protein 3 in the Phe-
lan-McDermid Syndrome 22q13.33 terminal deletion re-
gion that has been implicated in ASD [28]. PANX1 was
implicated in cis by multiple SNPs in multiple analyses
and across multiple tissues and has recently been shown
to play a role in N-methyl-D-aspartic acid-mediated epi-
leptiform activity [29]. In murine models, Panx1 and
Panx2 are strongly co-expressed early in the developing
brain, specifically in the hippocampus [30].
SLC25A12 is a 109 kb gene found on chromosome
2q31.1 and functions as a calcium-binding mitochondrial
protein, integral in the exchange of aspartate for glutamate
across the mitochondrial membrane. Several studies have
investigated the role of SLC25A12 in the development of
autism and SLC25A12 SNPs have been implicated [31-34].
Due to the platform used in the original AGP GWAS and
quality-based filtering of imputed eQTL data, only one of
the previously published SLC25A12 risk variants (rs908670)
was included in our study [31]. Rs908670 was identified as
an SLC25A12 eQTL in parietal tissue. Previous work has
found SLC25A12 to be differentially expressed in autism
brains compared to controls [22,35]. One such recent study
found SLC25A12 expression decreased in autism brains
compared to controls [22]. We found that the risk alleles of
the SLC25A12 eQTL SNPs identified in the AGP GWAS
are correlated with decreased expression of SLC25A12 in
the parietal lobe. We add our findings to this growing body
of evidence and suggest that common variation in
SLC25A12 auto-regulates expression and may contribute to
autism susceptibility.
Our study is limited by the available analyses and the
sample sizes used in the original GWAS. It is with some
caution that the comparison of results (for example, Strict|
All versus Spec|All) must be interpreted. Enrichment ana-
lyses, such as those conducted here, include only the top
SNP signals and therefore are sensitive to power and sam-
ple size differences between the GWAS scans that provide
the data to go into an enrichment analysis. It is not possible
to make direct comparisons between GWAS enrichment
results that differed with respect to sample size, ranging
from 720 subjects (Strict|WestEur) to 1,385 subjects (Spec|
All). However, within a single sample (for example, Spec|
All or Strict|WestEur), comparisons can easily be made be-
tween all tissues including cerebellum, parietal and LCLs.
Table 2 Pathway analyses of expression quantitative trait loci implicated genes














Thiamine metabolism Pathway 2 1 0.01 + 0.01
Nicotinic acetylcholine
receptor signaling
Pathway 97 3 0.63 + 0.03
P53 pathway
feedback loops 1
Pathway 7 1 0.05 + 0.05
Sensory perception Biological process 708 10 4.62 + 0.02
Sensory perception
of sound
Biological process 123 3 0.8 + 0.05
Carbohydrate metabolic
process
Biological process 952 2 6.22 - 0.05
Cell motion Biological process 964 11 6.29 + 0.05
Cell adhesion Biological process 1333 14 8.7 + 0.05
Immune system process Biological process 2628 24 17.16 + 0.05
Cell surface receptor
linked signal transduction
Biological process 2235 21 14.59 + 0.05
Structural constituent
of ribosome
Molecular function 194 5 1.27 + 0.009
Hydrolase activity Molecular function 2236 8 14.6 - 0.4
Receptor activity Molecular function 1808 18 11.8 + 0.5
Methyltransferase activity Molecular function 132 3 0.86 + 0.05
Analyses were conducted using the program PANTHER. All genes (N = 140) regulated by cis or trans acting eQTL were included in analysis to identify
over-representation of pathways, biological processes and molecular functions. A reference list (REFLIST) of annotated genes from the Homo sapiens genome
(N = 19,911) provided by PANTHER was used as a comparison to the autism eQTL gene list. One hundred and thirty autism eQTL implicated genes were
represented in the PANTHER databases, 10 eQTL target genes were not present in the PANTHER accessible databases. The type of pathway, biological process and
molecular function showing enrichment among these eQTL targets is provided as is the number of genes annotated to such data in the REFLIST, and in the
comparison autism list. Additionally, the number of genes expected in the autism eQTL list, given the number of genes in the REFLIST, is included. The
directionality of over- or under-representation in the PANTHER annotation database is included as well as the Bonferroni corrected P-value indicating the
statistical significance of the over- or under-representation of the biological process, molecular function or pathway in the autism eQTL gene list. eQTL: expression
quantitative trait loci.
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new insight into the biology of autism while allowing the
genetics community to leverage data from smaller studies
of GWAS. Our study provides evidence for the hypothesis
that SNPs below the genome-wide significant threshold
(P= 10-8) are functionally relevant to the development of
autism and may yet contribute to risk. Additionally, our
results point specifically to SLC25A12 and PANX1/2 and
to pathways (such as, methyltransferase, ribosomal com-
ponents) previously implicated in autism.
Conclusions
Our results demonstrate that loci moderately associated
with autism are more likely to be brain-specific eQTL
than randomly sampled loci conditioned on minor allele
frequency. Moreover, targets for the eQTL identified
among top signals from autism GWAS include compelling
candidate genes such as SLC25A12 and the pannexins.
These findings suggest that while very few SNPs from a
GWAS reach genome-wide significance, it is likely that an
abundance of SNPs at sub-significant thresholds are in-
deed associated with disease risk. This study providesfurther rationale for annotation-based approaches to
GWAS methods.
Additional files
Additional file 1: Table S1. Includes all eQTL from enrichment
analysis identified in parietal and cerebellar tissues, from all of the
four primary GWAS analyses. Worksheets provided in the database
include information on the eQTL target gene as well as the eQTL host
gene.
Additional file 2: Table S2. Provides additional information on each
gene that was targeted in cerebellum and parietal tissues by an
autism-associated eQTL SNP.
Additional file 3: Table S3. Provides additional supplementary data
regarding SLC25A12 eQTL including the original GWAS p-values
and z-scores, parietal tissue eQTL p-values and beta scores and
tagged and proxy SNPs for significant eQTL.
Abbreviations
ASD: autism spectrum disorder; AGP: Autism Genome Project;
eQTL: expression quantitative trait loci; GWAS: genome-wide association
study; LCL: lymphoblastoid cell line; PANX1: pannexin 1; PANX2: pannexin 2;
SNP: single nucleotide polymorphism; SLC25A12: solute carrier family 25
member 12.
Competing interests
The authors declare they have no competing interests.
Davis et al. Molecular Autism 2012, 3:3 Page 10 of 11
http://www.molecularautism.com/content/3/1/3Authors’ contributions
LKD conducted analyses and drafted the manuscript. EG conducted analyses
and assisted in drafting the manuscript. EKG assisted in drafting the
manuscript. JAB and CL conducted analyses yielding brain eQTL data and
participated in the drafting of the manuscript. EHC directed analyses and
assisted in drafting the manuscript. JS directed analyses of the study and
assisted in drafting the manuscript. NJC conceived of the study, directed
analyses and helped to draft the manuscript. All authors read and approved
of the final manuscript.
Acknowledgments
We wish to acknowledge the efforts made by the families who participated in
the original AGP GWAS. We also wish to acknowledge the AGP-GPAC for their
collection of the sample, dissemination of results and thoughtful discussion of
the methods and results in our paper. The project described was supported in
part by Grant Number by Grant Number R01 MH090937, P50MH094267, and
by Grant Number P50 HD055751 from the Eunice Kennedy Shriver National
Institute of Child Health and Human Development. Finally we would like to
thank Suma Jacob, MD, PhD, for her review of the manuscript.
Author details
1Section of Genetic Medicine, Department of Medicine, University of
Chicago, Chicago, IL 60637, USA. 2Division of Biostatistics and Epidemiology,
Medical University of South Carolina, Charleston, SC, USA. 3Department of
Psychiatry, University of Chicago, Chicago, IL 60637, USA. 4Department of
Psychiatry, University of Illinois, Chicago, IL 60608, USA. 5Vanderbilt Brain
Institute, Vanderbilt University, Nashville, TN 37232, USA.
Received: 27 January 2012 Accepted: 22 March 2012
Published: 16 May 2012
References
1. American Psychiatric Association: Diagnostic and Statistical Manual-IV-text
revision. Washington DC: American Psychiatric Association; 2000.
2. Folstein S, Rutter M: Genetic influences and infantile autism. Nature 1977,
265:726–728.
3. Ma D, Salyakina D, Jaworski JM, Konidari I, Whitehead PL, Andersen AN,
Hoffman JD, Slifer SH, Hedges DJ, Cukier HN, Griswold AJ, McCauley JL,
Beecham GW, Wright HH, Abramson RK, Martin ER, Hussman JP, Gilbert JR,
Cuccaro ML, Haines JL, Pericak-Vance MA: A genome-wide association
study of autism reveals a common novel risk locus at 5p14.1. Ann Hum
Genet 2009, 73:263–273.
4. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D,
Imielinski M, Bradfield JP, Sleiman PM, Kim CE, Hou C, Frackelton E,
Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J,
Estes A, Korvatska O, Piven J, Sonnenblick LI, Alvarez Retuerto AI, Herman EI,
Dong H, Hutman T, Sigman M, Ozonoff S, Klin A, et al: Common genetic
variants on 5p14.1 associate with autism spectrum disorders. Nature
2009, 459:528–533.
5. Weiss LA, Arking DE, Daly MJ, Chakravarti A: A genome-wide linkage and
association scan reveals novel loci for autism. Nature 2009, 461:802–808.
6. Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams
BS, Sykes N, Pagnamenta AT, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia
A, Berney T, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J,
Carson AR, Casallo G, Casey J, Chu SH, Cochrane L, Corsello C, Crawford EL,
Crossett A, et al: A genome-wide scan for common alleles affecting risk for
autism. Hum Mol Genet 2010, 19:4072–4082.
7. Curran S, Bolton P, Rozsnyai K, Chiocchetti A, Klauck SM, Duketis E, Poustka
F, Schlitt S, Freitag CM, Lee I, Muglia P, ITAN, Poot M, Staal W, de Jonge MV,
Ophoff RA, Lewis C, Skuse D, Mandy W, Vassos E, Fossdal R, Magnusson P,
Hreidarsson S, Saemundsen E, Stefansson H, Stefansson K, Collier D: No
association between a common single nucleotide polymorphism,
rs4141463, in the MACROD2 gene and autism spectrum disorder. Am J
Med Genet B Neuropsychiatr Genet 2011, 156B:633–639.
8. Lu AT, Cantor RM: Allowing for sex differences increases power in a
GWAS of multiplex Autism families. Mol Psychiatry 2012, 17(2):215–222.
9. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A,
Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL,
Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson
W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ,Anagnostou E, Sakurai T: Autism genome-wide copy number variation
reveals ubiquitin and neuronal genes. Nature 2009, 459:569–573.
10. Yaspan BL, Bush WS, Torstenson ES, Ma D, Pericak-Vance MA, Ritchie MD,
Sutcliffe JS, Haines JL: Genetic analysis of biological pathway data
through genomic randomization. Hum Genet 2011, 129:563–571.
11. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ: Trait-associated
SNPs are more likely to be eQTLs: annotation to enhance discovery from
GWAS. PLoS Genet 2010, 6:e1000888.
12. Below JE, Gamazon ER, Morrison JV, Konkashbaev A, Pluzhnikov A,
McKeigue PM, Parra EJ, Elbein SC, Hallman DM, Nicolae DL, Bell GI, Cruz M,
Cox NJ, Hanis CL: Genome-wide association and meta-analysis in
populations from Starr County, Texas, and Mexico City identify type 2
diabetes susceptibility loci and enrichment for expression quantitative
trait loci in top signals. Diabetologia 2011, 54:2047–2055.
13. Gamazon ER, Badner JA, Cheng L, Zhang C, Zhang D, Cox NJ, Gershon ES,
Kelsoe JR, Greenwood TA, Nievergelt CM, Chen C, McKinney R, Shilling PD,
Schork NJ, Smith EN, Bloss CS, Nurnberger JI, Edenberg HJ, Foroud T, Koller
DL, Scheftner WA, Coryell W, Rice J, Lawson WB, Nwulia EA, Hipolito M,
Byerley W, McMahon FJ, Schulze TG, Berrettini WH, et al: Enrichment of cis-
regulatory gene expression SNPs and methylation quantitative trait loci
among bipolar disorder susceptibility variants. Mol Psychiatry 2012, [Epub
ahead of print].
14. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL,
Dolan ME, Cox NJ: SCAN: SNP and copy number annotation.
Bioinformatics 2010, 26:259–262.
15. Duan S, Huang S, Zhang W, Bleibel W, Roe C, Clark T, Chen T, Schweitzer A,
Blume J, Cox NJ, Dolan ME: Genetic architecture of transcript-level
variation in humans. Am J Hum Genet 2008, 82:1101–1113.
16. Johnson WE, Li C, Rabinovic A: Adjusting batch effects in microarray
expression data using empirical Bayes methods. Biostatistics 2007, 8:118–127.
17. Leek JT, Storey JD: Capturing heterogeneity in gene expression studies
by surrogate variable analysis. PLoS Genet 2007, 3:1724–1735.
18. Li Y, Willer C, Ding J, Scheet P, Abecasis GR: MaCH: using sequence and
genotype data to estimate haplotypes and unobserved genotypes. Genet
Epidemiol 2010, 34:816–834.
19. Li Y, Willer C, Sanna S, Abecasis GR: Genotype imputation. Annu Rev
Genomics Hum Genet 2009, 10:387–406.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J,
Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-
genome association and population-based linkage analyses. Am J Hum
Genet 2007, 81:559–575.
21. Thomas PD, Kejariwal A, Campbell MJ, Mi H, Diemer K, Guo N, Ladunga I,
Ulitsky-Lazareva B, Muruganujan A, Rabkin S, Vandergriff JA, Doremieux O:
PANTHER: a browsable database of gene products organized by
biological function, using curated protein family and subfamily
classification. Nucl. Acids Res. 2003, 31:334–341.
22. Anney RJ, Kenny EM, O'Dushlaine C, Yaspan BL, Parkhomenka E, Buxbaum JD,
Sutcliffe J, Gill M, Gallagher L, Buxbaum JD, Sutcliffe J, Gill M, Gallagher L, Autism
Genome Project: Gene-ontology enrichment analysis in two independent
family-based samples highlights biologically plausible processes for autism
spectrum disorders. Eur J Hum Genet 2011, 19:1082–1089.
23. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor
RM, Blencowe BJ, Geschwind DH: Transcriptomic analysis of autistic brain
reveals convergent molecular pathology. Nature 2011, 474:380–384.
24. Pasca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Pasca AM, Cord
B, Palmer TD, Chikahisa S, Nishino S, Bernstein JA, Hallmayer J, Geschwind DH,
Dolmetsch RE: Using iPSC-derived neurons to uncover cellular phenotypes
associated with Timothy syndrome. Nat Med 2011, 17:1657–1662.
25. Ananiev G, Williams EC, Li H, Chang Q: Isogenic pairs of wild type and
mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome
patients as in vitro disease model. PLoS One 2011, 6:e25255.
26. Marchetto MC, Brennand KJ, Boyer LF, Gage FH: Induced pluripotent stem
cells (iPSCs) and neurological disease modeling: progress and promises.
Hum Mol Genet 2011, 20:R109–R115.
27. Swayne LA, Sorbara CD, Bennett SA: Pannexin 2 is expressed by postnatal
hippocampal neural progenitors and modulates neuronal commitment. J
Biol Chem 2010, 285:24977–24986.
28. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B,
Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J,
Spence SJ, Lee AT, Puura K, Lehtimäki T, Ledbetter D, Gregersen PK,
Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC,
Davis et al. Molecular Autism 2012, 3:3 Page 11 of 11
http://www.molecularautism.com/content/3/1/3Skuse D, Geschwind DH, Gilliam TC, et al: Strong association of de novo
copy number mutations with autism. Science 2007, 316:445–449.
29. Thompson RJ, Jackson MF, Olah ME, Rungta RL, Hines DJ, Beazely MA,
MacDonald JF, MacVicar BA: Activation of pannexin-1 hemichannels augments
aberrant bursting in the hippocampus. Science 2008, 322:1555–1559.
30. Vogt A, Hormuzdi SG, Monyer H: Pannexin1 and Pannexin2 expression in
the developing and mature rat brain. Brain Res Mol Brain Res 2005,
141:113–120.
31. Kim SJ, Silva RM, Flores CG, Jacob S, Guter S, Valcante G, Zaytoun AM, Cook
EH, Badner JA: A quantitative association study of SLC25A12 and
restricted repetitive behavior traits in autism spectrum disorders. Mol
Autism 2011, 2:8.
32. Sakurai T, Ramoz N, Barreto M, Gazdoiu M, Takahashi N, Gertner M, Dorr N,
Gama Sosa MA, De Gasperi R, Perez G, Schmeidler J, Mitropoulou V, Le HC,
Lupu M, Hof PR, Elder GA, Buxbaum JD: Slc25a12 disruption alters
myelination and neurofilaments: a model for a hypomyelination
syndrome and childhood neurodevelopmental disorders. Biol Psychiatry
2010, 67:887–894.
33. Silverman JM, Buxbaum JD, Ramoz N, Schmeidler J, Reichenberg A,
Hollander E, Angelo G, Smith CJ, Kryzak LA: Autism-related routines and
rituals associated with a mitochondrial aspartate/glutamate carrier
SLC25A12 polymorphism. Am J Med Genet B Neuropsychiatr Genet 2008,
147:408–410.
34. Ramoz N, Cai G, Reichert JG, Silverman JM, Buxbaum JD: An analysis of
candidate autism loci on chromosome 2q24-q33: evidence for
association to the STK39 gene. Am J Med Genet B Neuropsychiatr Genet
2008, 147B:1152–1158.
35. Lepagnol-Bestel AM, Maussion G, Boda B, Cardona A, Iwayama Y, Delezoide
AL, Moalic JM, Muller D, Dean B, Yoshikawa T, Gorwood P, Buxbaum JD,
Ramoz N, Simonneau M: SLC25A12 expression is associated with neurite
outgrowth and is upregulated in the prefrontal cortex of autistic
subjects. Mol Psychiatry 2008, 13:385–397.
doi:10.1186/2040-2392-3-3
Cite this article as: Davis et al.: Loci nominally associated with autism
from genome-wide analysis show enrichment of brain expression
quantitative trait loci but not lymphoblastoid cell line expression
quantitative trait loci. Molecular Autism 2012 3:3.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
